重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经过审计 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301373 证券简称：凌玮科技 公告编号：2025-58 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 单位：元 单位：元 ■ 3、现金流量表项目主要变动分析： □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √ ...

Fundraising Overview - The company raised a total of RMB 362.15 million through its initial public offering, with a net amount of RMB 313.72 million after deducting fees [1][2] - As of December 31, 2024, the company has used RMB 269.07 million of the raised funds, with a remaining balance of RMB 53.37 million in the fundraising account [2][3] Fund Management - The company has established a specific management method for the raised funds, ensuring they are stored in a dedicated account and used according to regulations [3][4] - The company has signed tripartite and quadripartite agreements with banks and sponsors to ensure strict approval processes for fund usage [3][4] Fund Usage - In 2024, the company utilized RMB 30.60 million for investment projects and RMB 10.60 million from over-raised funds to supplement working capital [2][6] - Cumulatively, the company has permanently supplemented working capital with RMB 54.82 million from over-raised funds as of December 31, 2024 [8] Project Changes - The company changed the project "Intelligent Storage Tank Remote Monitoring (RTM) System R&D" to "Intelligent Low-Voltage Distribution Solution R&D" due to market challenges [12][13] Compliance and Reporting - The company has complied with all relevant regulations regarding the management and usage of raised funds, with no violations reported [15][16] - The independent auditor confirmed that the company's fundraising activities were accurately reported and compliant with regulations [16][17]

登录新浪财经APP 搜索【信披】查看更多考评等级 (二)募集资金专户存储情况 截至2024年12月31日，募集资金存放专项账户的余额如下： 单位：人民币元 ■ 三、本年度募集资金的实际使用情况 本年内，本公司募集资金实际使用情况如下： （一）募集资金投资项目（以下简称"募投项目"）的资金使用情况 本公司2024年度募集资金实际使用情况详见附表《募集资金使用情况对照表》。 （二）募投项目先期投入及置换情况 截至2023年1月16日止，公司以自筹资金预先投入募投项目110,075,590.13元，以自筹资金预先支付发行 费用5,103,773.59元，合计115,179,363.72元。经公司2023年2月28日第三届董事会第六次会议和第三届监 事会第五次会议批准，同意公司使用募集资金 115,179,363.72元置换预先投入募投项目及已支付发行费 用的自筹资金。立信会计师事务所（特殊普通合伙）对公司使用募集资金置换预先投入募投项目及已支 付发行费用的自筹资金事项出具了信会师报字[2023]第ZF10069号专项鉴证报告，公司保荐机构、独立 董事和监事会对该事项均发表了同意意见。公司已于2023年3月将115, ...

Group 1 - The company, Mingxin Xuteng New Materials Co., Ltd., reported its fundraising activities and the management of raised funds for the year 2024, ensuring compliance with regulatory requirements [1][2][19] - The total amount raised from the initial public offering in 2020 was RMB 961.55 million, with a net amount of RMB 872 million after deducting related expenses [1][2] - In 2022, the company issued convertible bonds, raising RMB 673 million, with a net amount of RMB 663.64 million after expenses [2][3] Group 2 - The company has established special accounts for the management of raised funds, ensuring that funds are stored separately and used according to regulations [6][7] - As of December 31, 2024, the company had a balance of RMB 312.62 million in its fundraising accounts [43] - The company has utilized idle funds from the convertible bond issuance to temporarily supplement working capital, with a limit of RMB 300 million for a period not exceeding 12 months [39][44] Group 3 - The company has not used any excess funds for permanent working capital or to repay bank loans in 2024 [13][14] - The company has made adjustments to certain fundraising projects and has postponed the completion date for some projects without changing the intended use of funds [16][17] - The company has reported a net profit of -RMB 172.15 million for 2024, a decrease of 412.54% compared to the previous year [38] Group 4 - The automotive industry in China has shown resilience, with production and sales exceeding 31 million units in 2024, marking a year-on-year growth of 3.7% and 4.5% respectively [27][28] - The automotive interior materials industry is experiencing rapid growth driven by increasing consumer demand for high-quality and personalized products [29][30] - The company focuses on the research and development of new materials for automotive interiors, producing a range of products that meet safety and environmental standards [31][32]

2024年，品渥食品实现营业收入为8.76亿元，同比减少21.98%；归属于上市公司股东的净利润为698.84万元，上年同期亏损7337.08万元。 瑞财经 刘治颖 4月17日，品渥食品(SZ300892)发布2024年年度报告。 | | 2024 年 | 2023 年 | 本年比上年增波 | 2022年 | | --- | --- | --- | --- | --- | | 营业收入(元) | 876,445,513.08 | 1,123,334,693.30 | -21.98% | 1.538,747,962.42 | | 归属于上市公司股东 | 6.988.414.22 | -73.370.805.06 | 109.52% | 11.203.841.17 | | 的净利润(元) | | | | | | 归属于上市公司股东 的扣除非经常性损益 | 1,527,183.06 | -81,363,308,84 | 101.88% | 354,544.45 | | 的净利润(元) | | | | | | 经营活动产生的现金 | 97,543,117.86 | 6,236,533.00 | 1.464.06% | ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301331 证券简称：恩威医药 公告编号：2025-008 根据中国证券监督管理委员会发布的《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公 司自律监管指引第2号——创业板上市公司规范运作》及《上市公司监管指引第2号——上市公司募集资 金管理和使用的监管要求》等相关法律、法规和规范性文件规定，恩威医药股份有限公司（以下简 称"公司"或"本公司"）董事会编制了2024年度募集资金存放与实际使用情况的专项报告。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、募集资金基本情况 （一）募集资金金额及到位时间 经中国证券监督管理委员会《关于同意恩威医药股份有限公司首次公开发行股票注册的批复》（证监许 可[2022]1786号）同意注册，并经深圳证券交易所同意，公司首次向社会公开发行人民币普通股（A 股）股票17,540,000股，每股面值1.00元，发行价格为人民币29.80元/股。本次募集资金总额为人民币 522,692,000.00元，扣除发行费用（不含增值税）人民币79,741,650. ...

Core Viewpoint - The company has ensured the authenticity, accuracy, and completeness of its financial reports and other disclosures, taking legal responsibility for any misleading statements or omissions [2][3][4]. Financial Data - The first quarter financial statements for 2025 are unaudited, with the company confirming that there were no profits from mergers with controlled entities in the current or previous periods [5][6]. - The company has not adopted new accounting standards or interpretations that would affect the financial statements for the year [6]. Shareholder Information - The company has reported that there are no changes in the major shareholders or their shareholding status compared to the previous period [4]. Supervisory Board Meeting - The third supervisory board meeting was held on April 18, 2025, with all five supervisors present, and the meeting followed legal and procedural requirements [7]. - The supervisory board approved several key resolutions, including the annual work report, annual report and summary, profit distribution plan, and the special report on the use of raised funds [8][10][13][15]. Financial Reports and Budgets - The supervisory board confirmed that the 2024 annual financial statements accurately reflect the company's financial status and operational results, and the 2025 budget is deemed reasonable [17]. - The board also approved the evaluation report on internal controls, affirming that the company has established a sound internal control system [29]. Related Party Transactions - The supervisory board reviewed and approved the execution of related party transactions for 2024 and the expected transactions for 2025, confirming that they are conducted fairly and do not harm the interests of the company or its shareholders [20][25][26]. Accounting Estimates - The board approved changes in accounting estimates, stating that they provide a more reliable and relevant reflection of the company's financial status [27]. Quarterly Report - The supervisory board reviewed the first quarter report for 2025, confirming that it complies with legal and regulatory requirements and accurately reflects the company's operational and financial conditions [30].

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意开普云信息科技股份有限公司首次公 开发行股票注册的批复》（证监许可〔2020〕94号）同意，并经上海证券交易所同意，开普云信息科技 股份有限公司（以下简称"开普云"或"公司"）首次公开发行人民币普通股（A股）1,678.3360万股，每股 面值1.00元，每股发行价格为59.26元。本次公开发行募集资金总额为人民币99,458.19万元，扣除发行费 用人民币9,727.82万元（不含增值税），募集资金净额为人民币89,730.37万元。本次募集资金已于2020 年3月23日全部到位，天健会计师事务所（特殊普通合伙）于2020年3月23日对资金到位情况进行了审 验，并出具了《验资报告》（天健验[2020]7-21号）。 二、《募集资金专户存储三方监管协议》的签订情况和募集资金专户的开立情况 根据有关法律、法规及《上海证券交易所上市公司募集资金管理办法（2013年修订）》的要求，公司依 照规定对募集资 ...

截至 2024 年 12 月 31 日，公司及其子公司分别有 1 个募集资金专户，募集资金专户存放情况为合计 150,000,000.00 元，余额 39,615,113.47 元。 2024 年度募集资金使用用途和金额方面，募集资金总额 150,000,000.00 元，净额 150,000,000.00 元，加 利息收入 15,128.47 元，用于偿还借款 110,000,000.00 元，补充流动资金 400,015.00 元，截至 2024 年 12 月 31 日募集资金余额 39,615,113.47 元。公司未提前使用募集资金，且无募集资金用途变更情况。 2025年4月18日， 申万宏源证券承销保荐有限责任公司作为广东颐丰智慧农业股份有限公司（以下简称"颐丰智农"）的主 办券商，对其 2024 年度募集资金的存放与使用情况进行了专项核查。 2024 年 10 月 14 日，公司召开第三届董事会第十八次会议，审议通过相关议案，并于 2024 年第七次临 时股东大会审议通过。公司本次定向发行不超过 2,500 万股新股，股票发行价格为人民币 6 元/股，募 集资金总额为人民币 1.5 亿元，募集资金 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 国金证券股份有限公司（以下简称"保荐人"或"国金证券"）作为广东蒙泰高新纤维股份有限公司向不特 定对象发行可转换公司债券并在创业板上市的保荐人，根据《证券发行上市保荐业务管理办法（2023年 修订）》《深圳证券交易所创业板股票上市规则（2024年修订）》《深圳证券交易所上市公司自律监管 指引第 13 号——保荐业务》等规定，国金证券的持续督导期持续至2024年12月31日，截至本报告书出 具日，持续督导期已满，现根据有关法律法规和规范性文件的要求，出具本持续督导保荐总结报告书。 3、本保荐人及保荐代表人自愿接受中国证监会按照《证券发行上市保荐业务管理办法》的有关规定采 取的监管措施。 保荐人依照法律、行政法规和中国证监会及深圳证券交易所的有关规定，恪守业务规范和行业规范，诚 实守信、勤勉尽责，对蒙泰高新及其主要股东进行尽职调查，组织编制申请文件并出具推荐文件；提交 推荐文件后，主动配合深圳证券交易所、中国证监会的审核，组织蒙泰高新及中介机构对深圳证券交易 所、中国证监会的意见进行反馈答复，并与深圳证券交易所、中国证监会进行专业沟通；取得发行批复 文件后，按照深 ...